Chan Woo Kim
Overview
Explore the profile of Chan Woo Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1726
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nubong T, Kim C, Khetpal V, Hulten E, Ramirez V
R I Med J (2013)
. 2025 Jan;
108(2):9-15.
PMID: 39878657
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide. This review explores the evolving evidence base surrounding ASCVD prevention, particularly regarding nontraditional biomarkers, risk scores, and...
2.
Vu M, Shiwakoti S, Ko J, Bang G, Lee E, Kim E, et al.
Biochem Pharmacol
. 2024 Nov;
230(Pt 3):116614.
PMID: 39515588
Calcific aortic valve disease (CAVD) is a considerable health burden with a lack of effective therapeutic options. There is an urgent need to develop interventions that inhibit the osteogenic transformation...
3.
Kim C, Haji M, Lopes V, Halladay C, Sullivan J, Ross D, et al.
Am Heart J
. 2024 Aug;
278:48-60.
PMID: 39216692
Background: Hypertension is a leading risk factor for cardiovascular disease among patients living with HIV (PLWH). Understanding the predictors and patterns of antihypertensive medication prescription and blood pressure (BP) control...
4.
Kim S, Kim C, Moon Y, Kim H
Anim Cells Syst (Seoul)
. 2024 Apr;
28(1):123-136.
PMID: 38577621
The tumor microenvironment comprises both tumor and non-tumor stromal cells, including tumor-associated macrophages (TAMs), endothelial cells, and carcinoma-associated fibroblasts. TAMs, major components of non-tumor stromal cells, play a crucial role...
5.
Shin D, Kim S, Lee H, Lee H, Lee J, Park H, et al.
Nat Commun
. 2024 Mar;
15(1):2789.
PMID: 38555386
Proprotein convertase subtilisin/kexin type-9 (PCSK9) binds to and degrades low-density lipoprotein (LDL) receptor, leading to increase of LDL cholesterol in blood. Its blockers have emerged as promising therapeutics for cardiovascular...
6.
Kim S, Kim C, Kim H
Anim Cells Syst (Seoul)
. 2024 Feb;
28(1):55-65.
PMID: 38348341
Breast cancer is a frequently occurring malignant tumor that is one of the leading causes of cancer-related deaths in women worldwide. Monoclonal antibodies that block programed cell death 1 (PD-1)/programed...
7.
Choi S, Kim C, Park H, Park Y
Ann Occup Environ Med
. 2023 Dec;
35:e46.
PMID: 38148922
Background: As unpredictable work schedule (UWS) has increased worldwide, various studies have been conducted on the resulting health effects on workers. However, research on the effect of UWS on workers'...
8.
Kim E, Park E, Kim J, Lee E, Park S, Kim C, et al.
J Vis Exp
. 2023 Apr;
(193).
PMID: 37067288
Animal models are emerging as an important tool to understand the pathologic mechanisms underlying aortic valve stenosis (AVS) because of the lack of access to reliable sources of diseased human...
9.
Lim J, Kim C, Park H, Chung E, Chae C, Son J, et al.
Ann Occup Environ Med
. 2023 Apr;
35:e4.
PMID: 37063598
Background: Shift work has been shown to increase the risk of cardiovascular disease (CVD) based on several evidences. The classic risk factors of CVD include age, hypertension, smoking, obesity and...
10.
Kim H, Park K, Kim C, Lee K, Park H
Clin J Sport Med
. 2022 Oct;
32(6):e635-e643.
PMID: 36315829
Objective: To investigate the healing response of juvenile osteochondritis dissecans (JOCD) of the talus after conservative treatment, identify healing predictors, and develop a predictive model for healing. Design: Retrospective study....